Based on the metabolic engineering technology of synthetic biology, we use CRISPR gene editing to modify yeast and other chassis microorganisms, construct a dedicated engineering cell factory, and selectively synthesize rare natural active molecules in an intelligent closed fermentation system.
Abandoning high pollution chemical synthesis and low yield plant extraction processes, we aim to achieve low-cost, high-purity, and sustainable mass production of raw materials such as ginsenosides, melatonin, ergothionein, functional vitamins, and fish oil derivatives, providing green raw material solutions for the nutrition, health, beauty, and skincare industries.